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Abstract
Background
Depression is associated with an increased risk of dementia. However, short follow-up
times and lack of adjustment for familial factors in previous studies could influence this asso-
ciation. The purpose of the present study was to investigate the association between
depression and subsequent dementia, while controlling for familial factors and with a follow-
up of over 35 years.
Methods and findings
Two cohorts were formed from all individuals aged 50 years or older living in Sweden as of
31 December 2005 (n = 3,341,010). The Swedish National Patient Register was searched
from 1964 through 2016 to identify diagnosis of depression and dementia. In the first cohort,
individuals diagnosed with depression (n = 119,386) were matched 1:1 with controls without
depression diagnosis. The second cohort was a sibling cohort (n = 50,644) consisting of
same-sex full sibling pairs with discordant depression status. In the population matched
cohort study, a total of 9,802 individuals were diagnosed with dementia during a mean fol-
low-up time of 10.41 (range 0–35) years (5.5% of those diagnosed with depression and
2.6% of those without depression diagnosis (adjusted odds ratio [aOR] 2.47, 95% CI 2.35–
2.58; p < 0.001), with a stronger association for vascular dementia (aOR 2.68, 95% CI 2.44–
2.95; p < 0.001) than for Alzheimer disease (aOR 1.79, 95% CI 1.68–1.92; p < 0.001). The
association with dementia diagnosis was strongest in the first 6 months after depression
diagnosis (aOR 15.20, 95% CI 11.85–19.50; p < 0.001), then decreased rapidly but per-
sisted over follow-up of more than 20 years (aOR 1.58, 95% CI 1.27–1.98; p < 0.001). Also
in the sibling cohort, the association was strongest in the first 6 months (aOR 20.85, 95% CI
9.63–45.12; p < 0.001), then decreased rapidly but persisted over follow-up of more than 20
years (aOR 2.33, 95% CI 1.32–4.11; p < 0.001). The adjusted models included sex, age at
baseline, citizenship, civil status, household income, and diagnoses at baseline. The main
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003016 January 9, 2020 1 / 16
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Holmquist S, Nordstro¨m A, Nordstro¨m P
(2020) The association of depression with
subsequent dementia diagnosis: A Swedish
nationwide cohort study from 1964 to 2016. PLoS
Med 17(1): e1003016. https://doi.org/10.1371/
journal.pmed.1003016
Academic Editor: Carol Brayne, University of
Cambridge, UNITED KINGDOM
Received: August 27, 2019
Accepted: December 13, 2019
Published: January 9, 2020
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pmed.1003016
Copyright: © 2020 Holmquist et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data from the
Swedish National Patient Register (SNPR) can be
requested from the National Board of Health and
Welfare in Sweden (www.socialstyrelsen.se). The
limitation of the study methodology is the use of observational data; hence, the associations
found are not proof of causal effects.
Conclusions
Depression is associated with increased odds of dementia, even more than 20 years after
diagnosis of depression, and the association remains after adjustment for familial factors.
Further research is needed to investigate whether successful prevention and treatment of
depression decrease the risk of dementia.
Author summary
Why was this study done?
• Dementia is a leading cause of increased need for assistance worldwide among older
individuals. The risk of dementia has been associated with previous depression. How-
ever, the results from previous studies are not conclusive, there is a lack of studies with
long follow-up, and no study has evaluated whether familial factors may influence the
association.
What did the researchers do and find?
• From all inhabitants living in Sweden aged 50 years or older, 2 cohorts were formed: a
cohort of 119,386 individuals with depression matched 1:1 with controls without
depression, and a cohort of 50,644 full sibling pairs discordant for depression. Both
cohorts were evaluated for dementia during follow-up.
• In both cohorts, the risk of dementia was increased 10–20 times in the first year after a
diagnosis of depression. Thereafter the risk decreased rapidly but was still evident more
than 20 years after the diagnosis of depression.
• The risk of dementia was higher for those with a severe depression compared to those
with mild depression, and a stronger association was seen with vascular dementia.
What do these findings mean?
• The risk of dementia is increased for decades after a diagnosis of depression, where
those diagnosed with especially severe depressions are at increased risk.
Introduction
Dementia is common among the elderly, causing severe individual suffering as well as societal
strain [1]. As the proportion of people aged 65 years and above is rapidly increasing in the
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world population, the number of individuals with dementia is expected to double within 20
years, and this condition was estimated to have a worldwide cost of US$604 billion in 2010 [2].
Effective treatments for dementia remain scarce [3]; however, a preventive approach may be
possible through the identification of high-risk individuals and potentially modifiable risk fac-
tors [4–6].
An association between depression and subsequent dementia diagnosis has been suggested
in at least 4 independent meta-analyses—indicating close to a 2-fold higher risk of developing
dementia following depression [7–10]—as well as several reviews [11–14]. However, there is a
lack of studies with large samples and long follow-up, as well as adjustment for important
covariates, particularly familial factors. Depression preceding dementia has been discussed
both as a risk factor and possible prodrome [9,11], especially with regard to early versus late
onset of depression. Thus, several reviews suggest that depression in early life may be a risk fac-
tor of subsequent dementia diagnosis [11,13,14] and that depression in late life is rather a pro-
drome of dementia [11,13], but the literature is not consistent [12]. Some studies have found
an association with dementia more than a decade after onset of depression [15], whereas other
studies have failed to demonstrate such an association [16,17]. Furthermore, there is evidence
suggesting that the association between depression and dementia has a dose–response rela-
tionship [12,13,18–20], and the association may be dependent on the type of dementia
[13,21,22]. Given the sex differences in the prevalence of depression [23–25] and dementia
[26,27], the association may also differ between men and women. Finally, although it is well
known that both depression and dementia are influenced by both genetic and familial factors
[28–31], it has not been evaluated whether genetic and familial factors influence the associa-
tion between depression and dementia.
The aim of the present study was to investigate the association between depression and
dementia in a large nationwide cohort that included about 120,000 individuals diagnosed with
depression and matched controls. Based on a previous study, where we investigated the associ-
ation between traumatic brain injury and dementia [32], we hypothesized in particular that
the association between depression and dementia would persist decades after the depression
diagnosis, that the association would be independent of familial factors, and that the associa-
tion would be stronger with more severe depression for the outcome of vascular dementia.
Methods
This study is reported as per the Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) guideline (S1 STROBE Checklist).
Sample
The total cohort from which individuals were considered for inclusion consisted of all Swedish
residents�50 years old who were alive on 31 December 2005 (n = 3,341,010). A total of 813
individuals were excluded because of missing data on sex, date of birth, or citizenship, or
because the date of diagnosis for depression or dementia was postmortem in the national regis-
ters used in the present study. From the remaining total cohort (n = 3,340,197), 2 component
cohorts were formed and included in the study.
The first cohort consisted of individuals diagnosed with major depression (n = 119,386),
with no prior dementia diagnosis, each matched with 1 individual without a diagnosis of
depression during follow-up, on the basis of birth year and month, sex, and citizenship (Swed-
ish or non-Swedish). Baseline for both the individuals diagnosed with major depression and
their corresponding controls was at the date of depression diagnosis of the individual diag-
nosed with depression. Controls who died before baseline or were diagnosed with dementia
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before baseline were excluded, and a new control was searched from the remaining cohort of
potential controls. This procedure was repeated 3 times.
The second cohort was a sibling cohort (n = 50,644), consisting of same-sex full sibling
pairs with discordant depression status during follow-up. Baseline for both the affected sibling
and the unaffected sibling was set at the date of depression diagnosis of the affected sibling.
Sibling pairs where the unaffected sibling died before baseline or at least 1 of the siblings was
diagnosed with dementia before baseline were excluded. A few sibling pairs had discordant cit-
izenship status. The purpose of the sibling cohort was to control for the effect of early environ-
ment and genetic factors (i.e., familial factors).
Procedure
The Swedish National Patient Register (SNPR), controlled by the National Board of Health
and Welfare, was searched from 1 January 1964 through 31 December 2016 to identify diagno-
sis of major depression and dementia, classified according to the International Classification
of Diseases (ICD, 8th, 9th, and 10th revisions). Diagnosis of major depression included the
diagnosis codes F32 and F33 (ICD-10), 311 (ICD-9-SWE and ICD-8-SWE), and 296B (ICD-
9-SWE). For the F32 and F33 diagnosis codes, depression was coded as mild (F320, F330),
moderate (F321, F331), or severe (F322, F323, F332, F333). Depression was considered recur-
rent for diagnosis code F33 (recurrent depression; ICD-10) or at least 2 diagnoses of depres-
sion at least 6 months apart; otherwise, depression was considered as single episode. Diagnosis
of dementia was coded as Alzheimer dementia (ICD-10: F00, G30) or vascular dementia
(ICD-10: F01) and also included the diagnosis codes F039 (ICD-10) and 290 (ICD-8 and ICD-
9). Based on their association with the main exposure in the present study (major depression),
the main outcome (dementia), or death, the following covariates were selected and searched in
the SNPR using appropriate ICD codes: diabetes, myocardial infarction, alcohol intoxication,
drug intoxication, chronic pulmonary disease, renal failure, stroke, and hypothyroidism. The
SNPR has national coverage of close to 90% from 1970 to 1986 for inpatient care, and complete
coverage since 1987, and in a validation study showed predictive values of 85%–95% for most
diagnoses [33]. All Swedish physicians are obliged to report data for all care (except for pri-
mary care visits) to the SNPR, including psychiatric care from 1973 and hospital-based outpa-
tient care from 2001 [33]. Diagnosis of death was collected from the Swedish Cause of Death
Register, complete since 1961, also controlled by the National Board of Health and Welfare
and linked to each individual in the cohort. Data on citizenship (Swedish or non-Swedish),
civil status, and household income in 2005 were derived from Statistics Sweden (https://www.
scb.se), and linked to each individual in the cohort. There was no written prospective protocol
for the analysis; however, all analyses were preplanned based on the results of a previous study
[32].
Statistical analysis
In order to evaluate if the association between diagnosis of depression and subsequent diagno-
sis of dementia was time dependent, Schoenfeld’s residuals were calculated in Stata (version
12.1; StataCorp). Since the proportional hazards assumption was violated, the associations
were analyzed in time intervals between baseline and the end of follow-up. For this purpose,
multivariable conditional logistic regression analysis was performed in the 2 cohorts, with
dementia as the dependent variable. SPSS (version 25.0; IBM) was used for the data analysis.
The first model was unadjusted, but by design adjusted for sex, age at baseline, and citizenship
in the population matched cohort, and for sex and familial factors in the sibling cohort. A sec-
ond model was further adjusted for civil status, household income, and diagnoses at baseline
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in the population matched cohort, and for citizenship, age at baseline, civil status, household
income, and diagnoses at baseline in the sibling cohort (see Table 1). In the population
matched cohort study, separate analyses were performed by type of dementia (Alzheimer or
vascular dementia) and for different severity (mild, moderate, or severe) and frequency (1
diagnosis of depression or recurrent depression) of depressive episodes. Separate analyses
were also performed for men and women. The time dependency of the association between
depression and dementia in the 2 different cohorts was graphically illustrated using flexible
parametric models with 5 degrees of freedom (Fig 1) [34]. The knots were set in default posi-
tions. The differences between individuals based on depression diagnosis at baseline, in the
population matched cohort and sibling cohort, were investigated using chi-squared tests for
categorical data and independent samples t tests for continuous data. For all statistical analy-
ses, significance level was set at p< 0.05.
Ethical considerations
The Regional Ethical Review Board in Umeå (Nr 2013-86-31) and the National Board of
Health and Welfare approved the present study. The study was funded by the Swedish
Research Council (grant number 2016–02589). The funders had no role in the design, the
interpretation of the results, the decision to publish, or the preparation of the manuscript. As
data were analyzed anonymously, informed consent was not obtained from study participants.
Results
Characteristics of the sample
The characteristics of the population matched cohort and the sibling cohort are displayed in
Table 1. Chi-squared test and t tests revealed statistically significant differences between cases
and controls for civil status, household income, and diagnoses at baseline in the population
matched cohort, and for age at baseline, civil status, household income, and diagnoses at base-
line in the sibling cohort (all p< 0.001; see Table 1).
Time dependency of the association between depression and subsequent
dementia
Schoenfeld’s residuals showed that the proportional hazards assumption was violated in the
population matched cohort, indicating a time-dependent association between depression and
subsequent dementia.
Incident cases of dementia in the population matched cohort
In the population matched cohort study, a total of 9,802 individuals were diagnosed with
dementia during a mean follow-up time of 10.41 (SD 6.89; range 0–35) years (5.7% of those
diagnosed with depression and 2.6% of those without depression diagnosis; adjusted odds
ratio [aOR] 2.47, 95% CI 2.35–2.58; p< 0.001; Table 2). The cumulative incidence of dementia
during follow-up is illustrated in Fig 2. The association with dementia diagnosis was strongest
in the first 6 months after depression diagnosis (aOR 15.20, 95% CI 11.85–19.50; p< 0.001),
then decreased rapidly but persisted for more than 20 years (aOR 1.58, 95% CI 1.27–1.98;
p< 0.001; Table 2).
Incident cases of dementia in the sibling cohort
In the sibling cohort, a total of 1,161 individuals were diagnosed with dementia during a mean
follow-up of 11.04 (SD 6.96; range 0–31) years, 3.4% of those diagnosed with depression and
Depression and dementia
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Table 1. Cohort characteristics.
Characteristic Matched cohort (n = 238,772) Sibling cohort (n = 50,644)
Depression (n
= 119,386)
No depression
(n = 119,386)
Group difference: depression
versus no depression
Depression (n
= 25,322)
No depression
(n = 25,322)
Group difference: depression
versus no depression
Age at baseline in years,
mean (SD)
63.79 (11.89) 59.10 (8.85) 59.97 (8.91) t (50,639.38) = 11.01, p< 0.001
(2-tailed); 95% CI of the
difference = 0.71–1.02
Citizenship χ2 (df = 1, n = 50,644) = 0.026,
p = 0.87 (2-sided)
Non-Swedish 42,928 (18.0%) 1,698 (6.7%) 1,689 (6.7%)
Swedish 195,844 (82.0%) 23,624 (93.3%) 23,633 (93.3%)
Sex
Male 93,758 (39.3%) 21,416 (42.3%)
Female 145,014 (60.7%) 29,228 (57.7%)
Civil status χ2 (df = 4, n = 238,040) =
4,120.52, p< 0.001 (2-sided)
χ2 (df = 4, n = 55,540) = 815.07,
p< 0.001 (2-sided)
Married 53,478 (44.8%) 67,873 (56.9%) 12,108 (47.8%) 15,165 (59.9%)
Unmarried 18,009 (15.1%) 13,934 (11.7%) 4,614 (18.2%) 3,695 (14.6%)
Divorced 30,333 (25.4%) 20,600 (17.3%) 7,117 (28.1%) 5,006 (19.8%)
Widowed 17,297 (14.5%) 16,394 (13.7%) 1,413 (5.7%) 1,370 (5.4%)
Other 78 (0.1%) 44 (<0.1%) 21 (0.1%) 13 (0.1%)
Missing 191 (0.2%) 541 (0.5%) 31 (0.1%) 73 (0.3%)
Yearly household income
in Swedish krona, mean
(SD); approximate
equivalent in US dollars�
255,808
(339,534);
$26,368
(35,350)
311,620
(489,856);
$32,429
(50,977)
t (211,706.04) = 32.31, p< 0.001
(2-tailed); 95% CI of the
difference = 52,425.27–59,197.42
291,265
(438,927);
$30,324
(45,705)
340,819
(346,022);
$5,485
(36,027)
t (47,977.85) = 14.01, p< 0.001
(2-tailed); 95% CI of the
difference = 42,664.91–
56,443.49
Diagnoses at baseline
Diabetes 6,281 (5.3%) 4,368 (3.7%) χ2 (df = 1, n = 238,772) = 359.70,
p< 0.001 (2-sided)
1,172 (4.6%) 816 (3.2%) χ2 (df = 1, n = 50,644) = 66.36,
p< 0.001 (2-sided)
Myocardial infarction 5,634 (4.7%) 4,177 (3.5%) χ2 (df = 1, n = 238,772) = 225.65,
p< 0.001 (2-sided)
800 (3.2%) 644 (2.5%) χ2 (df = 1, n = 50,644) = 17.35,
p< 0.001 (2-sided)
Alcohol intoxication 7,803 (6.5%) 1,736 (1.5%) χ2 (df = 1, n = 238,772) =
4,019.31, p< 0.001 (2-sided)
1,977 (7.8%) 605 (2.4%) χ2 (df = 1, n = 50,644) = 768.21,
p< 0.001 (2-sided)
Drug intoxication 1,763 (1.5%) 346 (0.3%) χ2 (df = 1, n = 238,772) = 960.54,
p< 0.001 (2-sided)
418 (1.7%) 115 (0.5%) χ2 (df = 1, n = 50,644) = 174.08,
p< 0.001 (2-sided)
Chronic pulmonary disease 3,028 (2.5%) 1,477 (1.2%) χ2 (df = 1, n = 238,772) = 544.25,
p< 0.001 (2-sided)
594 (2.3%) 315 (1.2%) χ2 (df = 1, n = 50,644) = 87.20,
p< 0.001 (2-sided)
Renal failure 1,325 (1.1%) 708 (0.6%) χ2 (df = 1, n = 238,772) = 188.86,
p< 0.001 (2-sided)
245 (1.0%) 122 (0.5%) χ2 (df = 1, n = 50,644) = 41.52.,
p< 0.001 (2-sided)
Stroke 5,461 (4.6%) 2,967 (2.5%) χ2 (df = 1, n = 238,772) = 765.02,
p< 0.001 (2-sided)
857 (3.4%) 454 (1.8%) χ2 (df = 1, n = 50,644) = 127.17,
p< 0.001 (2-sided)
Hypothyroidism 2,622 (2.2%) 1,589 (1.3%) χ2 (df = 1, n = 238,772) = 257.95,
p< 0.001 (2-sided)
495 (2.0%) 299 (1.2%) χ2 (df = 1, n = 50,644) = 49.15,
p< 0.001 (2-sided)
Survival time in years,
mean (SD)
10.04 (6.91) 10.79 (6.86) t (238,754.64) = 26.80, p< 0.001
(2-tailed); 95% CI of the
difference = 0.70–0.81
10.78 (7.00) 11.30 (6.90) t (50,631.57) = 8.39, p< 0.001
(2-tailed); 95% CI of the
difference = 0.40–0.64
Data are number (percent) unless otherwise indicated. Information on citizenship, civil status, and household income was derived from Statistics Sweden for the year of
2005.
�Using 2019 exchange rate: 1:0.104.
https://doi.org/10.1371/journal.pmed.1003016.t001
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1.2% of those without depression diagnosis (aOR 3.75, 95% CI 3.24–4.34; p< 0.001; Table 3).
The cumulative incidence of dementia during follow-up in the sibling cohort is illustrated in
Fig 3. As in the population matched cohort, the association with dementia diagnosis was stron-
gest the first 6 months after depression diagnosis (aOR 20.85, 95% CI 9.63–45.12; p< 0.001),
then decreased rapidly but persisted over follow-up of more than 20 years (aOR 2.33, 95% CI
1.32–4.11; p< 0.001; Table 3).
Severity and frequency of depression, type of dementia, and patient sex in
the population matched cohort
The severity of the depression influenced the association with dementia (Table 4). Thus, after a
mild depression, the risk of subsequent dementia remained elevated 5–9.9 years after depres-
sion diagnosis (aOR 1.96, 95% CI 1.39–2.75; p< 0.001) but not at�10 years after depression
diagnosis (aOR 1.39, 95% CI 0.83–2.36; p = 0.212). In contrast, the association remained signif-
icant at�10 years after depression diagnosis for both for moderate depression (aOR 1.41, 95%
CI 1.02–1.95; p = 0.037) and for severe depression (aOR 1.75, 95% CI 1.29–2.36; p< 0.001).
No clear differences were found between a single episode of depression and recurrent
Fig 1. Association between depression and the risk of dementia during follow-up for 238,772 individuals. Individuals with follow-up time of less
than 1 month were excluded. The figure was constructed using a flexible parametric model with 5 degrees of freedom and knots in default positions.
The black line represents the hazard ratio, and the grey areas represent 95% confidence intervals.
https://doi.org/10.1371/journal.pmed.1003016.g001
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Table 2. Associations between depression and the risk of subsequent dementia diagnosis during follow-up in 119,386 individuals diagnosed with depression and
119,386 matched controls without depression diagnosis: Population matched cohort (n = 238,772).
Time after depression diagnosis Individuals at risk Diagnosed with dementia Unadjusted� Adjusted��
Total Cases Controls OR 95% CI p-Value OR 95% CI p-Value
Count Percent Count Percent
Overall 238,772 9,802 6,752 5.66% 3,050 2.55% 2.37 2.27–2.48 <0.001 2.47 2.35–2.58 <0.001
0–5.9 months 238,772 1,043 972 0.81% 71 0.06% 14.06 11.01–17.95 <0.001 15.20 11.85–19.50 <0.001
6–11.9 months 232,274 750 652 0.57% 98 0.08% 7.24 5.80–9.03 <0.001 7.83 6.24–9.83 <0.001
1–1.9 years 226,605 1,006 816 0.73% 190 0.17% 4.48 4.09–5.73 <0.001 5.15 4.33–6.12 <0.001
2–4.9 years 215,680 2,129 1,474 1.40% 655 0.59% 2.58 2.34–2.86 <0.001 2.62 2.36–2.91 <0.001
5–9.9 years 180,192 2,289 1,384 1.59% 914 0.98% 1.83 1.67–2.01 <0.001 1.85 1.68–2.05 <0.001
10–20 years 112,027 2,095 1,187 2.21% 908 1.55% 1.54 1.40–1.70 <0.001 1.58 1.43–1.75 <0.001
20 years or more 26,044 481 267 2.19% 214 1.55% 1.60 1.30–1.97 <0.001 1.58 1.27–1.98 <0.001
ORs and 95% confidence intervals were derived from conditional logistic regression analysis.
�By design adjusted for sex, age at baseline, and citizenship.
��Further adjusted for civil status, household income, and diagnoses at baseline: diabetes, myocardial infarction, alcohol intoxication, drug intoxication, chronic
pulmonary disease, renal failure, stroke, and hypothyroidism.
OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1003016.t002
Fig 2. Cumulative incidence of dementia after depression diagnosis in the matched cohort of 119,386 individuals with depression and 119,386
individuals with no depression during follow-up. The number of individuals at risk at each time point is presented below the graph.
https://doi.org/10.1371/journal.pmed.1003016.g002
Depression and dementia
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003016 January 9, 2020 8 / 16
Table 3. Associations between depression and the risk of subsequent dementia diagnosis during follow-up for 25,322 full sibling pairs with discordant depression
status at baseline: Sibling cohort (n = 50,644).
Time after depression diagnosis Individuals at risk Diagnosed with dementia Unadjusted� Adjusted��
Total Cases Controls OR 95% CI p-Value OR 95% CI p-Value
Count Percent Count Percent
Overall 50,644 1,161 864 3.41% 297 1.17% 3.16 2.75–3.64 <0.001 3.75 3.24–4.34 <0.001
0–5.9 months 50,644 135 128 0.51% 7 0.03% 18.29 8.55–39.13 <0.001 20.85 9.63–45.12 <0.001
6–11.9 months 49,600 86 82 0.33% 4 0.02% 20.25 7.42–55.26 <0.001 24.39 8.82–67.45 <0.001
1–1.9 years 48,609 136 116 0.48% 20 0.08% 5.80 3.61–9.32 <0.001 7.07 4.33–11.54 <0.001
2–4.9 years 46,666 228 174 0.76% 54 0.23% 3.49 2.54–4.79 <0.001 4.25 3.04–5.94 <0.001
5–9.9 years 39,894 248 156 0.80% 92 0.45% 1.86 1.41–2.45 <0.001 2.03 1.51–2.72 <0.001
10–20 years 25,708 252 159 1.27% 93 0.70% 1.96 1.49–2.58 <0.001 2.50 1.86–3.35 <0.001
20 years or more 6,296 76 49 1.61% 27 0.83% 1.95 1.15–3.30 0.013 2.33 1.32–4.11 <0.001
ORs and confidence intervals were derived from conditional logistic regression analysis.
�By use of a sibling design, adjusted for sex and familial factors.
��Further adjusted for citizenship, age at baseline, civil status, household income, and diagnoses at baseline: diabetes, myocardial infarction, alcohol intoxication, drug
intoxication, chronic pulmonary disease, renal failure, stroke, and hypothyroidism.
OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1003016.t003
Fig 3. Cumulative incidence of dementia after depression diagnosis in 25,322 sibling pairs discordant for depression diagnosis. The number of
individuals at risk at each time point is presented below the graph.
https://doi.org/10.1371/journal.pmed.1003016.g003
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depression or between men and women (Table 5). The type of dementia also influenced the
magnitude of the association. The association was stronger for vascular dementia than for Alz-
heimer disease, and remained at�20 years only for vascular dementia (aOR 1.64, 95% CI
1.02–2.62; p = 0.040, Table 5).
Discussion
The results of the present nationwide study indicated increased odds for dementia diagnosis
after depression, even when the depression occurred 20 years or more before the dementia
diagnosis and while adjusting for a set of covariates including sex, age at baseline, citizenship,
civil status, household income, and diagnoses at baseline. The association was strongest when
dementia occurred within the first 6 months after depression diagnosis, and then decreased
rapidly but remained statistically significant, with an OR of close to 1.6 at a follow-up time of
20 years or more. The results were consistent when controlling for familial factors in a
Table 4. The risk of dementia diagnosis during follow-up for individuals diagnosed with mild depression (n = 10,030), moderate depression (n = 24,746), and severe
depression (n = 20,540), compared to matched controls.
Time after depression diagnosis Individuals at risk Diagnosed with dementia Unadjusted� Adjusted��
OR 95% CI p-Value OR 95% CI p-Value
Mild depression (n = 20,060)
Overall 20,060 728 2.75 2.32–3.26 <0.001 2.85 2.38–3.39 <0.001
0–5.9 months 20,060 75 17.75 6.48–48.60 <0.001 18.02 6.53–49.71 <0.001
6–11.9 months 19,495 69 5.70 2.91–11.16 <0.001 5.61 2.83–11.11 <0.001
1–1.9 years 18,921 82 4.57 2.56–8.15 <0.001 4.26 2.33–7.80 <0.001
2–4.9 years 17,840 222 3.74 2.66–5.25 <0.001 3.98 2.79–5.68 <0.001
5–9.9 years 14,269 191 1.91 1.38–2.65 <0.001 1.96 1.39–2.75 <0.001
10+ years 7,117 89 1.33 0.81–2.20 0.258 1.39 0.83–2.36 0.212
Moderate depression (n = 49,492)
Overall 49,492 1,426 2.07 1.84–2.32 <0.001 2.16 1.92–2.43 <0.001
0–5.9 months 49,492 124 11.40 5.97–21.76 <0.001 11.66 6.06–22.43 <0.001
6–11.9 months 48,309 108 5.63 3.31–9.57 <0.001 5.93 3.46–10.18 <0.001
1–1.9 years 47,092 178 3.50 2.44–5.02 <0.001 3.70 2.56–5.36 <0.001
2–4.9 years 44,802 367 2.14 1.70–2.69 <0.001 2.16 1.71–2.74 <0.001
5–9.9 years 36,401 417 1.58 1.27–1.96 <0.001 1.56 1.25–1.95 <0.001
10+ years 19,177 229 1.36 1.00–1.85 0.053 1.41 1.02–1.95 0.037
Severe depression (n = 41,080)
Overall 41,080 1,479 2.32 2.07–2.61 <0.001 2.36 2.10–2.66 <0.001
0–5.9 months 41,080 127 20.17 8.88–45.78 <0.001 20.99 9.21–47.89 <0.001
6–11.9 months 39,951 130 6.38 3.76–10.80 <0.001 6.77 3.96–11.58 <0.001
1–1.9 years 38,896 152 6.42 3.96–10.41 <0.001 6.08 3.71–9.97 <0.001
2–4.9 years 36,939 396 2.32 1.85–2.90 <0.001 2.43 1.92–3.06 <0.001
5–9.9 years 30,558 403 1.78 1.43–2.22 <0.001 1.77 1.41–2.22 <0.001
10+ years 17,095 281 1.80 1.35–2.39 <0.001 1.75 1.29–2.36 <0.001
Classification of the severity of the depression based of the International Classification of Diseases–10th revision. ORs and confidence intervals were derived from
conditional logistic regression analysis.
�By design adjusted for patient sex, age at baseline, and citizenship.
��Further adjusted for civil status, household income, and diagnoses at baseline: diabetes, myocardial infarction, alcohol intoxication, drug intoxication, chronic
pulmonary disease, renal failure, stroke, and hypothyroidism.
OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1003016.t004
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Table 5. Risk of dementia diagnosis during follow-up for individuals with diagnosed single depression (n = 56,522) and recurrent depression (n = 62,864), for men
with depression (n = 46,879) and women with depression (n = 75,507), and for Alzheimer disease and vascular dementia separately, compared to matched controls.
Time after depression diagnosis Individuals at risk Diagnosed with dementia Unadjusted Adjusted
OR 95% CI p-Value OR 95% CI p-Value
Single depressive episode (n = 113,044)�
Overall 113,044 4,992 2.32 2.18–2.48 <0.001 2.48 2.32–2.65 <0.001
0–5.9 months 113,044 837 16.77 12.49–22.50 <0.001 18.82 13.92–25.45 <0.001
6–11.9 months 107,693 506 7.45 5.66–9.80 <0.001 8.17 6.17–10.82 <0.001
1–1.9 years 103,787 547 4.42 3.53–5.52 <0.001 5.06 4.01–6.39 <0.001
2–4.9 years 97,340 1,070 2.46 2.13–2.84 <0.001 2.63 2.26–3.06 <0.001
5–9.9 years 78,049 987 1.51 1.31–1.74 <0.001 1.51 1.30–1.75 <0.001
10–19.9 years 47,002 839 1.13 0.97–1.32 0.108 1.14 0.97–1.34 0.107
20 years or more 12,736 206 1.56 1.13–2.15 0.007 1.61 1.14–2.26 0.006
Recurrent depression (n = 125,728)�
Overall 125,728 4,810 2.43 2.27–2.59 <0.001 2.47 2.31–2.64 <0.001
0–5.9 months 125,728 206 8.27 5.32–12.88 <0.001 8.47 5.41–13.27 <0.001
6–11.9 months 124,581 244 6.84 4.69–9.97 <0.001 7.54 5.11–11.13 <0.001
1–1.9 years 122,818 459 5.41 4.20–6.99 <0.001 5.38 4.15–6.99 <0.001
2–4.9 years 118,340 1,059 2.70 2.35–3.11 <0.001 2.66 2.31–3.07 <0.001
5–9.9 years 102,143 1,311 2.10 1.86–2.38 <0.001 2.14 1.87–2.44 <0.001
10–19.9 years 65,025 1,256 1.90 1.67–2.16 <0.001 1.96 1.72–2.23 <0.001
20 years or more 13,308 275 1.63 1.24–2.15 <0.001 1.55 1.16–2.09 <0.001
Men (n = 93,758)��
Overall 90,375 3,383 2.52 2.33–2.72 <0.001 2.63 2.43–2.85 <0.001
0–5.9 months 90,375 380 17.90 11.41–28.08 <0.001 19.59 12.32–30.98 <0.001
6–11.9 months 90,855 284 7.18 5.01–10.27 <0.001 7.92 5.48–11.44 <0.001
1–1.9 years 89,239 378 4.68 3.57–6.15 <0.001 4.87 3.67–6.46 <0.001
2–4.9 years 83,664 725 2.83 2.37–3.37 <0.001 2.81 2.34–3.38 <0.001
5–9.9 years 68,972 777 2.07 1.75–2.44 <0.001 2.06 1.73–2.45 <0.001
10–19.9 years 42,485 693 1.68 1.42–1.99 <0.001 1.78 1.49–2.12 <0.001
20 years or more 9,752 146 1.46 1.01–2.12 0.050 1.41 0.95–2.11 0.091
Women (n = 145,014)��
Overall 145,014 6,419 2.30 2.18–2.43 <0.001 2.38 2.25–2.52 <0.001
0–5.9 months 145,014 663 12.49 9.34–16.71 <0.001 13.42 9.97–18.05 <0.001
6–11.9 months 144,419 446 7.27 5.49–9.64 <0.001 7.83 5.86–10.45 <0.001
1–1.9 years 138,312 628 4.94 3.99–6.12 <0.001 5.35 4.30–6.67 <0.001
2–4.9 years 132,016 1,404 2.47 2.19–2.79 <0.001 2.54 2.24–2.89 <0.001
5–9.9 years 111,220 1,521 1.73 1.54–1.93 <0.001 1.76 1.57–1.98 <0.001
10–19.9 years 69,542 1,402 1.48 1.31–1.66 <0.001 1.50 1.33–1.69 <0.001
20 years or more 16,292 335 1.67 1.30–2.15 <0.001 1.66 1.27–2.17 <0.001
Alzheimer disease (n = 238,772)�
Overall 238,772 4,201 1.65 1.54–1.75 <0.001 1.79 1.68–1.92 <0.001
0–5.9 months 238,772 470 10.19 7.42–13.99 <0.001 11.32 8.20–15.61 <0.001
6–11.9 months 232,274 343 5.66 4.19–7.65 <0.001 6.39 4.69–8.71 <0.001
1–1.9 years 226,605 462 3.96 3.13–4.99 <0.001 4.56 3.58–5.80 <0.001
2–4.9 years 215,680 918 1.94 1.68–2.24 <0.001 2.13 1.84–2.47 <0.001
5–9.9 years 180,192 978 1.21 1.05–1.38 0.007 1.28 1.11–1.47 0.001
10–19.9 years 112,027 825 0.89 0.77–1.04 0.13 0.97 0.83–1.23 0.657
20 years or more 26,044 205 0.99 0.73–1.34 0.938 0.97 0.70–1.34 0.854
(Continued)
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nationwide sibling cohort. The results supported our hypothesis of an association between
depression and dementia persisting decades after the depression diagnosis date, independent
of familial factors.
Although an association between depression and risk of subsequent dementia has been
established previously [7,8,11,12,35], the nature of the association has not been explored in
great detail. In studies with short follow-up times, the association may reflect several different
potential underlying relationships: depressive symptoms might be a characteristic of the pro-
dromal phase of dementia, the patient might in fact already have dementia although yet undi-
agnosed, or the depression might be discovered and diagnosed when the patient is under
evaluation for dementia. Additionally, lack of evaluation of important covariates increases the
risk of confounding and bias. In the present study, the maximum follow-up time was 35 years,
and the association between depression and subsequent risk of dementia was consistent for
more than 20 years of follow-up. In addition, the association remained after adjusting for an
array of important covariates including medical conditions and socioeconomic factors. The
results were similar for men and women, suggesting an association independent of patient sex.
To the best of our knowledge, it has not been previously established whether the association
between dementia and depression remains after controlling for familial factors. This is of
importance as early environmental or genetic factors may mediate the association between
depression and subsequent dementia. Interestingly, in a previous study using a twin design,
there was an association between depression and dementia [16]. However, 40% of the demen-
tia diagnoses occurred within 4 years of the depression, and the study sample was small, which
limited the possibility of evaluating the association during longer follow-up times; the study
also lacked covariates. Thus, the association found may well represent depression in individu-
als with undiagnosed dementia, or dementia in an early phase. In the present study we con-
trolled for familial factors using a sibling design including more than 25,000 sibling pairs. The
results from the sibling cohort showed an association between depression and subsequent risk
of dementia that lasted for more than 20 years. Thus, the association was similar to that found
Table 5. (Continued)
Time after depression diagnosis Individuals at risk Diagnosed with dementia Unadjusted Adjusted
OR 95% CI p-Value OR 95% CI p-Value
Vascular dementia (n = 238,772)�
Overall 238,772 2,329 2.74 2.50–3.01 <0.001 2.68 2.44–2.95 <0.001
0–5.9 months 238,772 254 20.17 11.30–36.01 <0.001 21.19 11.51–39.00 <0.001
6–11.9 months 232,274 188 9.17 5.64–14.91 <0.001 9.54 5.81–15.66 <0.001
1–1.9 years 226,605 241 6.00 4.15–8.67 <0.001 5.61 3.84–8.17 <0.001
2–4.9 years 215,680 523 3.06 2.48–3.77 <0.001 2.72 2.19–3.37 <0.001
5–9.9 years 180,192 529 2.37 1.93–2.90 <0.001 2.36 1.91–2.91 <0.001
10–19.9 years 112,027 491 1.72 1.42–2.10 <0.001 1.69 1.37–2.07 <0.001
20 years or more 26,044 103 1.58 1.02–2.44 0.041 1.64 1.02–2.62 0.040
Depression was considered as recurrent for diagnosis code F33 (recurrent depression; ICD-10) or at least 2 diagnoses of depression at least 6 months apart; otherwise,
depression was considered as a single episode. ORs and confidence intervals were derived from conditional logistic regression analysis.
�Unadjusted model is by design adjusted for patient sex, age at baseline, and citizenship. Adjusted model is further adjusted for civil status, household income, and
diagnoses at baseline: diabetes, myocardial infarction, alcohol intoxication, drug intoxication, chronic pulmonary disease, renal failure, stroke, and hypothyroidism.
��Unadjusted model is by design adjusted for age at baseline and citizenship. Adjusted model is further adjusted for civil status, household income, and diagnoses at
baseline: diabetes, myocardial infarction, alcohol intoxication, drug intoxication, chronic pulmonary disease, renal failure, stroke, and hypothyroidism.
OR, odds ratio.
https://doi.org/10.1371/journal.pmed.1003016.t005
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in the population matched cohort study, suggesting an association between the 2 diagnoses
independent of genetic and early environmental factors.
It is also not clear from previous studies whether the association between depression and
dementia is dependent on dementia type [13,21,22]. Our results indicate that the association is
stronger and covers a wider timespan for vascular dementia than for Alzheimer disease: For
vascular dementia, the risk remained statistically significant over a follow-up of more than 20
years, whereas for Alzheimer disease the association remained statistically significant for less
than 10 years. The association of depression with Alzheimer disease may best be described as
reflecting prodromal depressive symptoms [36]. With respect to the stronger association with
vascular dementia, it could be that depression induces the inflammatory process of atheroscle-
rosis that is known to begin already early in life [37]. This hypothesis has support from a recent
study in which Setiawan and others [38] found signs of increased activation of microglia in
certain areas of the brain in individuals after a major depression, as well as from a study noting
cerebrovascular disease in depressed elderly individuals to be associated with cognitive decline
[39]. Yet, given the observational design of these studies and our study, no causal inferences
can be made. Previous studies [18–20] and reviews [12,13] have suggested a dose–response
relationship between depression and the risk of subsequent dementia. In the present study the
association between depression and risk of subsequent dementia remained statistically signifi-
cant for moderate and severe depression for a follow-up of more than 10 years, in contrast to
mild depression. However, the association was similar for a single episode of depression and
recurrent depression. Thus, our hypothesis of a dose–response relationship between depres-
sion and subsequent dementia was only partly supported. Again, whether this dose–response
relationship indicates a causal relationship cannot be determined in the present study.
Thus, a limitation of the present study is the use of observational data. Possible explanations
for the found association between depression and dementia include depression as a risk factor
for dementia, and depression and dementia being associated based on meditating pathogene-
sis. In particular, there is increased risk of reverse causality for those diagnosed with dementia
shortly after a depression diagnosis, where the association may reflect depressive symptoms as
a prodrome of yet-undiagnosed dementia, or individuals who are evaluated for dementia also
being diagnosed with depression due to more intense healthcare. Moreover, even though we
controlled for civil status and household income, we were not able to account for additional
socioeconomic factors, e.g., education level. Additionally, since the SNPR doesn’t include data
from general practice, some of the individuals included in the study may have been diagnosed
with either dementia or depression in a primary care setting. Additionally, a limitation of our
study is that the results here may not necessarily generalize to individuals who were diagnosed
in a primary care setting because the individuals included in the study were diagnosed in spe-
cialty care, and as such may represent more severe cases of depression/dementia. This may
also explain the lower than expected rates of depression and dementia in our study, since
many patients are diagnosed exclusively in primary care: Previous studies have indicated that
the prevalence of both depression and dementia is around 10% in older community-dwelling
individuals [40,41]. Nevertheless, our results distinctly reveal a long-lasting association
between depression and subsequent risk of developing dementia, information that may be use-
ful in the identification of individuals potentially at high risk for development of dementia in
late life. A potential limitation in the present study is the use of ORs instead of risk ratios, since
the use of ORs can result in non-collapsibility, i.e., that estimated ORs are not similar to the
relative risks. However, this potential problem seems to be of minor importance as the esti-
mated relative risks and ORs for the different time intervals were similar in the present study.
Strengths of the present study include the use of clinically confirmed diagnoses of depression
and dementia made in specialist care. Other strengths include the nationwide cohort studied,
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the long follow-up of up to 35 years, and the use of a sibling design to control for familial fac-
tors, all together increasing the external validity.
In conclusion, depression diagnosis is associated with increased odds of subsequent demen-
tia diagnosis, even when the depression diagnosis occurs more than 20 years before the
dementia diagnosis. The association was stronger for vascular dementia than for Alzheimer
disease, which might suggest that depression contributes to the inflammatory process charac-
teristic of atherosclerosis specifically in the brain. It would be of interest if future longitudinal
studies could evaluate whether any inflammatory process associated with depression is
reduced locally in the brain if depression is successfully treated, and whether the successful
treatment of a depressive episode reduces the later risk of dementia.
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